Clinical development of new drug-radiotherapy combinations.
In countries with the best cancer outcomes, approximately 60% of patients receive radiotherapy as part of their treatment, which is one of the most cost-effective cancer treatments. Notably, around 40% of cancer cures include the use of radiotherapy, either as a single modality or combined with othe...
Main Authors: | Sharma, R, Plummer, R, Stock, J, Greenhalgh, T, Hawkins, M, NCRI CTRad Academia-Pharma Joint Working Group |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Similar Items
-
Combination of novel agents with radiotherapy to treat rectal cancer
by: Greenhalgh, T, et al.
Published: (2015) -
Clinical advances of hypoxia-activated prodrugs in combination with radiotherapy
by: Mistry, I, et al.
Published: (2017) -
Multimodality functional imaging in rectal cancer treated with radiotherapy
by: Greenhalgh, T
Published: (2022) -
Stereotactic body radiotherapy for liver metastases.
by: Aitken, K, et al.
Published: (2015) -
Proton beam therapy – the challenges of delivering high-quality evidence of clinical benefit
by: National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group, et al.
Published: (2018)